Hologic has obtained a CE mark in Europe for Affirm, its contrast biopsy software for use in contrast-enhanced mammography (CEM). Affirm facilitates the targeting and acquisition of tissue samples ...

April 22nd, 2016 Medgadget Editors Ob/Gyn, Radiology, Surgery Hologic won FDA clearance and is releasing its Affirm prone biopsy guidance system, a product already approved in Europe.

Hologic (HOLX) announced that its Affirm Contrast Biopsy Software, which combines contrast-enhanced diagnostic capabilities with accurate lesion targeting to help streamline workflow and ...

April 21 (Reuters) - HologicBy Reuters April 21, 201612:16 PM UTCUpdated ago April 21 (Reuters) - Hologic * announces FDA clearance and commercial availability Of Affirm Prone Biopsy System, First ...

DECATUR, Ala. (WAFF) - A new technology at the Decatur-Morgan hospital is helping women receive more accurate and less invasive mammograms and breast biopsies. The new technology is called the ...